Search research articles
Contact Us
Filters
Showing results (1591-1600 of 1,873) with videos related to
Page
of 188
Sort By:
The Lancet. Diabetes & Endocrinology
|
November 13, 2022
Efficacy and safety of dapagliflozin in patients with heart failure with mildly reduced or preserved ejection fraction by baseline glycaemic status (DELIVER): a subgroup analysis from an international, multicentre, double-blind, randomised, placebo-controlled trial
Silvio E Inzucchi, Brian L Claggett, Muthiah Vaduganathan, et al.
JACC. Heart Failure
|
May 25, 2023
Cardio-Renal-Metabolic Overlap, Outcomes, and Dapagliflozin in Heart Failure With Mildly Reduced or Preserved Ejection Fraction
John W Ostrominski, Jorge Thierer, Brian L Claggett, et al.
The New England Journal of Medicine
|
July 6, 2017
Declining Risk of Sudden Death in Heart Failure
Li Shen, Pardeep S Jhund, Mark C Petrie, et al.
Molecular Syndromology
|
November 30, 2011
TGIF Mutations in Human Holoprosencephaly: Correlation between Genotype and Phenotype
A A Keaton, B D Solomon, E F Kauvar, et al.
Circulation
|
November 20, 2014
Regional variation in patients and outcomes in the Treatment of Preserved Cardiac Function Heart Failure With an Aldosterone Antagonist (TOPCAT) trial
Marc A Pfeffer, Brian Claggett, Susan F Assmann, et al.
European Heart Journal. Cardiovascular Pharmacotherapy
|
August 21, 2025
Sacubitril/valsartan and Quality of Life Assessed Using the EuroQol 5-Dimension 3-Level Questionnaire Level Sum Score (EQ-5D-3L-LSS) in Patients with HFrEF and HFmrEF/HFpEF
Mingming Yang, Alasdair D Henderson, Inder S Anand, et al.
Circulation
|
April 11, 2023
Endothelin-1, Outcomes in Patients With Heart Failure and Reduced Ejection Fraction, and Effects of Dapagliflozin: Findings From DAPA-HF
Su Ern Yeoh, Kieran F Docherty, Ross T Campbell, et al.
European Journal of Heart Failure
|
August 22, 2024
Clinical characteristics and outcomes of patients aged 80 years and over with heart failure: Need for better treatment
Mingming Yang, Toru Kondo, Inder S Anand, et al.
Journal of the American Heart Association
|
April 23, 2025
Prognostic Significance of Nutritional Scores in Patients With Heart Failure: Insights From the PARAGON-HF Trial
Henri Lu, Brian L Claggett, Masatoshi Minamisawa, et al.
JACC. Heart Failure
|
April 26, 2025
Concomitant Aficamten and Disopyramide in Symptomatic Obstructive Hypertrophic Cardiomyopathy
Ahmad Masri, Martin S Maron, Theodore P Abraham, et al.
Page
of 188
Search research articles
Search
Showing results (1591-1600 of 1,873) with videos related to
Sort By:
Page
of 188
The Lancet. Diabetes & Endocrinology
|
November 13, 2022
Efficacy and safety of dapagliflozin in patients with heart failure with mildly reduced or preserved ejection fraction by baseline glycaemic status (DELIVER): a subgroup analysis from an international, multicentre, double-blind, randomised, placebo-controlled trial
Silvio E Inzucchi, Brian L Claggett, Muthiah Vaduganathan, et al.
JACC. Heart Failure
|
May 25, 2023
Cardio-Renal-Metabolic Overlap, Outcomes, and Dapagliflozin in Heart Failure With Mildly Reduced or Preserved Ejection Fraction
John W Ostrominski, Jorge Thierer, Brian L Claggett, et al.
The New England Journal of Medicine
|
July 6, 2017
Declining Risk of Sudden Death in Heart Failure
Li Shen, Pardeep S Jhund, Mark C Petrie, et al.
Molecular Syndromology
|
November 30, 2011
TGIF Mutations in Human Holoprosencephaly: Correlation between Genotype and Phenotype
A A Keaton, B D Solomon, E F Kauvar, et al.
Circulation
|
November 20, 2014
Regional variation in patients and outcomes in the Treatment of Preserved Cardiac Function Heart Failure With an Aldosterone Antagonist (TOPCAT) trial
Marc A Pfeffer, Brian Claggett, Susan F Assmann, et al.
European Heart Journal. Cardiovascular Pharmacotherapy
|
August 21, 2025
Sacubitril/valsartan and Quality of Life Assessed Using the EuroQol 5-Dimension 3-Level Questionnaire Level Sum Score (EQ-5D-3L-LSS) in Patients with HFrEF and HFmrEF/HFpEF
Mingming Yang, Alasdair D Henderson, Inder S Anand, et al.
Circulation
|
April 11, 2023
Endothelin-1, Outcomes in Patients With Heart Failure and Reduced Ejection Fraction, and Effects of Dapagliflozin: Findings From DAPA-HF
Su Ern Yeoh, Kieran F Docherty, Ross T Campbell, et al.
European Journal of Heart Failure
|
August 22, 2024
Clinical characteristics and outcomes of patients aged 80 years and over with heart failure: Need for better treatment
Mingming Yang, Toru Kondo, Inder S Anand, et al.
Journal of the American Heart Association
|
April 23, 2025
Prognostic Significance of Nutritional Scores in Patients With Heart Failure: Insights From the PARAGON-HF Trial
Henri Lu, Brian L Claggett, Masatoshi Minamisawa, et al.
JACC. Heart Failure
|
April 26, 2025
Concomitant Aficamten and Disopyramide in Symptomatic Obstructive Hypertrophic Cardiomyopathy
Ahmad Masri, Martin S Maron, Theodore P Abraham, et al.
Page
of 188